M&A Report

Surging Demand for COVID-19 Testing Forces Thermo Fisher to Raise Its Offer for Qiagen

Back in March, Thermo Fisher Scientific announced that it had agreed to acquire Qiagen for $11.5 billion. At the time, the €39 (roughly $46) per share representing a premium of 23 percent over the … [Read more...]

Diagnostics Deals

3M and MIT Team Up to Create Rapid, Scalable SARS-CoV-2 Antigen Test

Unlike reverse transcription-polymerase chain reaction (PCR) and blood-based serology antibody assays, antigen tests are relatively inexpensive to produce and generate results rapidly at the point of … [Read more...]

Inside the Lab Industry 

Humana, LabCorp, Quest and Walmart Partner on At-Home & Drive-Thru COVID-19 Testing

Humana is teaming up with the country’s biggest retailer and two biggest testing labs to make it easier for members to get COVID-19 testing in non-traditional diagnostics settings. First, the national … [Read more...]

Diagnostics Deals

Global Non-Profit & Smartphone DX Firm to Create Malaria Diagnosis App

Malaria continues to wreak havoc around the world, particularly in low- and middle-income countries (LMICs). Although rapid in vitro diagnostic tests (RDTs) for malaria are widely used in those … [Read more...]

M&A Report

Invitae-ArcherDX Merger to Create Precision Oncology Powerhouse

While M&A deal volume remains abnormally low, business is expected to pick up this summer as the reopening process gets into high gear. Meanwhile, a few new deals are being made, including … [Read more...]

M&A Report

Thermo Fisher Acquisition of Qiagen Remains on Track

COVID-19 continues to cast a pall on strategic M&A activity in the diagnostics space with the key players monitoring events before making their moves. However, there are still a few smaller deals … [Read more...]

Diagnostics Deals

Pandemic Infuses New Urgency Into Effort to Develop Genomics-Based Early PTSD Detection Diagnostics

In addition to death and dislocation, the global COVID-19 pandemic is likely to spawn a crisis in mental health, including a spike in post-traumatic syndrome disorder (PTSD) cases. With this in mind, … [Read more...]

M&A Report

Danaher Closes $21.4 Billion GE Biopharma Acquisition

Although the COVID-19 pandemic has had a chilling effect on strategic acquisitions, M&A activity is still taking place, including the conclusion of the biggest deal in the diagnostics space in … [Read more...]

Diagnostic Deals

How Curative & KorvaLabs Created a Successful COVID-19 Testing Lab in Less than a Month

Say what you will about the current state and availability of COVID-19 diagnostic testing, the energetic, imaginative and speedy response by certain segments of the lab industry has been nothing short … [Read more...]

Diagnostic Deals

Labs, Universities and Even Computer Companies Target Point-of-Care COVID-19 Test Development

The imperative to create and provide tests capable of detecting the SARS-CoV-2 virus that causes COVID-19 coronavirus continues to fuel strategic deal making. SARS-CoV-2 point-of-care tests was the … [Read more...]